Commentary: 'Epidemiologic transition' interrupted or sweep to the second stage of 'health transition'?

International Journal of Epidemiology

Volumn 36, Issue 2, 2007, Pages 384-386

  Vallin, Jacques ^a  

^a INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARDIOVASCULAR DISEASE; DEMOGRAPHY; DEVELOPING COUNTRY; EPIDEMIOLOGICAL DATA; HEALTH CARE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; MORTALITY; NOTE; POLITICS; POPULATION DYNAMICS; PRIORITY JOURNAL; REGISTRATION; SOCIOECONOMICS; STATISTICAL ANALYSIS;

CAUSE OF DEATH; FEMALE; HEALTH TRANSITION; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; LIFE EXPECTANCY; MALE; MORTALITY; POPULATION DYNAMICS; THAILAND;

EID: 34447302845     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym054     Document Type: Note

References (17)

1. Hill K, Vapattanawong P, Prasartkul P, Porapakkham Y, Limm SS, Lopez AD. Epidemiologic transition interrupted: A reassessment of mrotality trends in Thailand, 1980-2000. Int J Epidemiol.
2. Omran AR. The epidemiologic transition: A theory of the epidemiology of population change. Milbank Memorial Fund Quarterly 1971;49 509-38.
3. Frenk J, Bobadilla JL, Stern C, Frejka T, Lozano R. Elements for a theory of the health transition. Health transition review 1991; 1:21-38.
4. Mesle F, Vallin J. Développement économique et espérance de vie: La transition sanitaire an tournant des années soixante In: Congrès international de la population, Vol. 2. Montréal: Liège UIESP, 1993. p. 365-82.
5. Mesle F, Vallin J. The health transition: Trends and prospects. In: Caselli G, Vallin J and Wunsch G eds. Demography, analysis and synthesis. A treatise in demography. New York: Elsevier, 2006. p. 247-602.
6. Grmek MD. Préliminaires d'une étude historique des maladies. Annales ESC 1969;24:1473-83.
7. Biraben JN. Les pathocénoses en Europe. In: Grmek M (coor.). Histoire des maladies. Paris: Association économie et santé, pag. mult. 1999;1-36. (Séminaire sur l'histoire des maladies, Courchevel, 18-20 mars 1996).
8. Vallin J. Diseases, deaths, and life expectancy. Genus. 2005; 61:279-96. (Proceedings of the International Conference "Trends and problems of the world population in the XXI century. 50 years since Rome 1954, Rome, 26-28 May 2005).
9. Vallin J, Berlinguer G. From endogenous to the maximum human life span. In: Caselli G, Vallin J and Wunsch G eds. Demography, analysis and synthesis. A treatise in demography. New York: Elsevier, 2005. p. 94-1162.
10. Vallin J, Mesle F. Trends in mortality in Europe since 1950: Age-, sex- and cause-spécific mortality. In: Council of Europe (ed). Trends in mortality and differential mortality 2001;31-186. Strasbourg, Council of Europe Publishing, 334p. (Population Studies ndeg 36).
11. Fries JF. The compression of morbidity. Milbank Quarterly 1983; 61:397-419.
12. Olshansky SJ, Carnes BA, Cassel C. In search of Mathuselah: Estimating the upper limits to human longevity. Science 1990;250:634-40.
13. Vaupel JW, Lundstrom H. Longer life expectancy? Evidence from Sweden of reductions in mortality rates at advanced ages. In: Wise DA ed. Studies in the economics of aging. Chicago: University of Chicago Press, 1994. p. 79-104.
14. Kannisto V, Iauritsen J, Thatcher AR, Vaupel JW. Reductions in mortality at advanced ages: Several decades of evidence from 27 countries. Population and Development Review 1994,20:793-810.
15. Oeppen J, Vaupel JW. Broken limits to life expectancy. Science 2002; 1029-31.
16. Mesle F, Vallin J. Diverging trends in female old-age mortality: The United States and the Netherlands versus France and Japan. Population and Development Review 2006;32:123-45.
17. Vallin J, Mesle F. Convergences and divergences in mortality: A new approach to health transition. Demographic Research 2004; 12-43. (Special Collection 2. Article 2, Determinants of Diverging Trends in Mortality, available at http//www.demograpbic-research.org/special/2/2/).